Considering benefit and risk before routinely recommending SpaceOAR

Lancet Oncol. 2021 Jan;22(1):11-13. doi: 10.1016/S1470-2045(20)30639-2.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brachytherapy / adverse effects
  • Brachytherapy / instrumentation*
  • Evidence-Based Medicine
  • Humans
  • Male
  • Organs at Risk
  • Patient Safety
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Dosage*
  • Radiation Injuries / etiology
  • Radiation Injuries / prevention & control*
  • Rectum / radiation effects*
  • Risk Assessment
  • Risk Factors